Literature DB >> 7544886

Stereospecificity of human DNA polymerases alpha, beta, gamma, delta and epsilon, HIV-reverse transcriptase, HSV-1 DNA polymerase, calf thymus terminal transferase and Escherichia coli DNA polymerase I in recognizing D- and L-thymidine 5'-triphosphate as substrate.

F Focher1, G Maga, A Bendiscioli, M Capobianco, F Colonna, A Garbesi, S Spadari.   

Abstract

L-beta-Deoxythymidine (L-dT), the optical enantiomer of D-beta-deoxythymidine (D-dT), and L-enantiomers of nucleoside analogs, such as 5-iodo-2'-deoxy-L-uridine (L-IdU) and E-5-(2-bromovinyl)-2'-deoxy-L-uridine (L-BVdU), are not recognized in vitro by human cytosolic thymidine kinase (TK), but are phosphorylated by herpes simplex virus type 1 (HSV-1) TK and inhibit HSV-1 proliferation in infected cells. Here we report that: (i) L-dT is selectively phosphorylated in vivo to L-dTMP by HSV-1 TK and L-dTMP is further phosphorylated to the di- and triphosphate forms by non-stereospecific cellular kinases; (ii) L-dTTP not only inhibits HSV-1 DNA polymerase in vitro, but also human DNA polymerase alpha, gamma, delta and epsilon, human immunodeficiency virus reverse transcriptase (HIV-1 RT), Escherichia coli DNA polymerase 1 and calf thymus terminal transferase, although DNA polymerase beta was resistant; (iii) whereas DNA polymerase beta, gamma, delta and epsilon are unable to utilize L-dTTP as a substrate, the other DNA polymerases clearly incorporate at least one L-dTMP residue, with DNA polymerase alpha and HIV-1 RT able to further elongate the DNA chain by catalyzing the formation of the phosphodiester bond between the incorporated L-dTMP and an incoming L-dTTP; (iv) incorporated L-nucleotides at the 3'-OH terminus make DNA more resistant to 3'-->5' exonucleases. In conclusion, our results suggest a possible mechanism for the inhibition of viral proliferation by L-nucleosides.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544886      PMCID: PMC307120          DOI: 10.1093/nar/23.15.2840

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  18 in total

1.  Enzymologic mechanism of calf thymus DNA polymerase delta.

Authors:  L Ng; C K Tan; K M Downey; P A Fisher
Journal:  J Biol Chem       Date:  1991-06-25       Impact factor: 5.157

2.  Activity profiles of enzymes that control the uracil incorporation into DNA during neuronal development.

Authors:  F Focher; P Mazzarello; A Verri; U Hübscher; S Spadari
Journal:  Mutat Res       Date:  1990-03       Impact factor: 2.433

3.  Herpes simplex-1 DNA polymerase. Identification of an intrinsic 5'----3' exonuclease with ribonuclease H activity.

Authors:  J J Crute; I R Lehman
Journal:  J Biol Chem       Date:  1989-11-15       Impact factor: 5.157

4.  DNA polymerase epsilon interacts with proliferating cell nuclear antigen in primer recognition and elongation.

Authors:  G Maga; U Hübscher
Journal:  Biochemistry       Date:  1995-01-24       Impact factor: 3.162

5.  Identity of DNA polymerase gamma from synaptosomal mitochondria and rat-brain nuclei.

Authors:  U Hübscher; C C Kuenzle; S Spadari
Journal:  Eur J Biochem       Date:  1977-12-01

6.  Biochemical and functional comparison of DNA polymerases alpha, delta, and epsilon from calf thymus.

Authors:  T Weiser; M Gassmann; P Thömmes; E Ferrari; P Hafkemeyer; U Hübscher
Journal:  J Biol Chem       Date:  1991-06-05       Impact factor: 5.157

7.  Calf thymus DNA polymerase delta independent of proliferating cell nuclear antigen (PCNA).

Authors:  F Focher; M Gassmann; P Hafkemeyer; E Ferrari; S Spadari; U Hübscher
Journal:  Nucleic Acids Res       Date:  1989-03-11       Impact factor: 16.971

8.  Biochemical pharmacology of (+)- and (-)-2',3'-dideoxy-3'-thiacytidine as anti-hepatitis B virus agents.

Authors:  C N Chang; V Skalski; J H Zhou; Y C Cheng
Journal:  J Biol Chem       Date:  1992-11-05       Impact factor: 5.157

9.  L-thymidine is phosphorylated by herpes simplex virus type 1 thymidine kinase and inhibits viral growth.

Authors:  S Spadari; G Maga; F Focher; G Ciarrocchi; R Manservigi; F Arcamone; M Capobianco; A Carcuro; F Colonna; S Iotti
Journal:  J Med Chem       Date:  1992-10-30       Impact factor: 7.446

10.  Calf thymus DNA polymerase delta: purification, biochemical and functional properties of the enzyme after its separation from DNA polymerase alpha, a DNA dependent ATPase and proliferating cell nuclear antigen.

Authors:  F Focher; S Spadari; B Ginelli; M Hottiger; M Gassmann; U Hübscher
Journal:  Nucleic Acids Res       Date:  1988-07-25       Impact factor: 16.971

View more
  11 in total

1.  Cell fate control gene therapy based on engineered variants of human deoxycytidine kinase.

Authors:  Anton Neschadim; James C M Wang; Takeya Sato; Daniel H Fowler; Arnon Lavie; Jeffrey A Medin
Journal:  Mol Ther       Date:  2012-01-24       Impact factor: 11.454

2.  L-ATP is recognized by some cellular and viral enzymes: does chance drive enzymic enantioselectivity?

Authors:  A Verri; A Montecucco; G Gosselin; V Boudou; J L Imbach; S Spadari; F Focher
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

3.  A synthetic molecular system capable of mirror-image genetic replication and transcription.

Authors:  Zimou Wang; Weiliang Xu; Lei Liu; Ting F Zhu
Journal:  Nat Chem       Date:  2016-05-16       Impact factor: 24.427

4.  Strong and selective inhibitors of hepatitis B virus replication among novel N4-hydroxy- and 5-methyl-beta-L-deoxycytidine analogues.

Authors:  E Matthes; A Funk; I Krahn; K Gaertner; M von Janta-Lipinski; L Lin; H Will; H Sirma
Journal:  Antimicrob Agents Chemother       Date:  2007-04-02       Impact factor: 5.191

5.  Stereochemical control of DNA biosynthesis.

Authors:  V V Sosunov; F Santamaria; L S Victorova; G Gosselin; B Rayner; A A Krayevsky
Journal:  Nucleic Acids Res       Date:  2000-03-01       Impact factor: 16.971

6.  Molecular modeling approach to understanding the mode of action of L-nucleosides as antiviral agents.

Authors:  K Lee; C K Chu
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

7.  Antiviral L-nucleosides specific for hepatitis B virus infection.

Authors:  M L Bryant; E G Bridges; L Placidi; A Faraj; A G Loi; C Pierra; D Dukhan; G Gosselin; J L Imbach; B Hernandez; A Juodawlkis; B Tennant; B Korba; P Cote; P Marion; E Cretton-Scott; R F Schinazi; J P Sommadossi
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

Review 8.  Structural basis of HIV inhibition by L-nucleosides: Opportunities for drug development and repurposing.

Authors:  Francesc X Ruiz; Anthony Hoang; Christopher R Dilmore; Jeffrey J DeStefano; Eddy Arnold
Journal:  Drug Discov Today       Date:  2022-02-23       Impact factor: 8.369

9.  Internal 32P-labeling of L-deoxyoligonucleotides.

Authors:  Christian Frauendorf; Felix Hausch; Ingo Röhl; Andrea Lichte; Stefan Vonhoff; Sven Klussmann
Journal:  Nucleic Acids Res       Date:  2003-04-01       Impact factor: 16.971

10.  Enzymatic synthesis of DNA strands containing α-L-LNA (α-L-configured locked nucleic acid) thymine nucleotides.

Authors:  Torben Højland; Rakesh N Veedu; Birte Vester; Jesper Wengel
Journal:  Artif DNA PNA XNA       Date:  2012 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.